We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Endo Settles N.Y. Claims That It Falsely Promoted Opioid
Endo Settles N.Y. Claims That It Falsely Promoted Opioid
Amid the backdrop of the national opioid epidemic, Endo Pharmaceuticals has settled false advertising allegations concerning its promotion of the painkiller Opana ER, according to the New York Attorney General’s Office.